Roche Cobas influenza A and B virus nucleic acid test reagent - Taiwan Registration c5454be6264ea819ed0b80a80c4f9061
Access comprehensive regulatory information for Roche Cobas influenza A and B virus nucleic acid test reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c5454be6264ea819ed0b80a80c4f9061 and manufactured by ROCHE MOLECULAR SYSTEMS, INC.. The authorized representative in Taiwan is ROCHE DIAGNOSTICS LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is suitable for the Cobas Liat system, which uses multiplex reverse transcription polymerase to automatically react in real time to quickly detect and identify signs and symptoms of respiratory infection and whether influenza A and B virus RNA is present on the nasopharyngeal swab specimen of patients with clinical and epidemiological risk factors.
C Immunology and Microbiology; A Clinical chemistry and clinical toxicology
C.3980 Nucleic acid test for respiratory viruses; A.1660 Quality control materials (analytical and non-analytical)
import
Dates and Status
May 25, 2018
May 25, 2023